Skip to content
OpenCapital
Get started

AdaptHealth AHCO Diabetes Health — Adjusted EBITDA

Similar metrics at other companies

International Flavors & Fragrances logo
IFFHealth & Biosciences — Adjusted Operating EBITDA
$153M+10.9%
IDEX logo
IEXHealth & Science Technologies — Segment Adjusted EBITDA
$106M+21.3%
Clarivate logo
CLVTLife Sciences & Healthcare — Adjusted EBITDA
$29.2M-4.6%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Segment Adjusted Operating EBITDA
$153M+10.9%
Clorox logo
CLXHealth and Wellness — Segment Adjusted EBIT
$158M-6.5%
Cleveland-Cliffs logo
CLFOther Businesses — Adjusted EBITDA
$15M+50.0%

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.5%
Enterprise value$3.32B+4.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept ahco:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's diabetes health — adjusted ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's diabetes health — adjusted EBITDA?
AdaptHealth (AHCO) reported diabetes health — adjusted EBITDA of $4.14M in Q1 2026.
How has AdaptHealth's diabetes health — adjusted EBITDA changed year-over-year?
AdaptHealth's diabetes health — adjusted EBITDA decreased by 35.2% year-over-year, from $6.39M to $4.14M.
What is the long-term trend for AdaptHealth's diabetes health — adjusted EBITDA?
Over 3 years (2022 to 2025), AdaptHealth's diabetes health — adjusted EBITDA has grown at a -29.2% compound annual growth rate (CAGR), from $73.38M to $26.07M.
What does diabetes health — adjusted EBITDA mean?
Measures the operational profitability of the diabetes health segment by excluding interest, taxes, depreciation, amortization, and non-recurring items. It serves as a key performance indicator for the segment's core cash-generating capability and operational health.